SCHEMBL7242534

SCHEMBL7242534

Nc1cccc2ccc3ccc4ccc5ccc6ccccc6c5c4c3c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 8/20 0.60
ALDH1A1 P00352 8/20 0.60
HPGD P15428 6/20 0.60
TSHR P16473 6/20 0.60
CYP3A4 P08684 5/20 0.60
KEAP1 Q14145 1/20 0.60
CYP1A2 P05177 3/20 0.56
THRB P10828 1/20 0.56
TDP1 Q9NUW8 3/20 0.46
CYP2A6 P11509 1/20 0.46
HPRT1 P00492 2/20 0.45
ERBB2 P04626 1/20 0.45
FYN P06241 1/20 0.45
MAOA P21397 1/20 0.45
ACHE P22303 1/20 0.45
AHR P35869 1/20 0.45
TYMS P04818 2/20 0.42
CYP1B1 Q16678 2/20 0.42
CYP1A1 P04798 1/20 0.42
JAK2 O60674 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31158232 0.91 ALDH1A1 (0.65) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL3630203 0.91 ALDH1A1 (0.65) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL28712139 0.89 ALDH1A1 (0.62) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL29518611 0.89 ALDH1A1 (0.62) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL18600581 0.88 HSD17B10 (0.58) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL14742902 0.83 ALDH1A1 (0.59) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL29613364 0.83 HSD17B10 (0.68) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL4851942 0.83 HSD17B10 (0.68) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL29568709 0.83 HSD17B10 (0.68) HSD17B10ALDH1A1HPGDTSHRCYP3A4
SCHEMBL29569839 0.83 HSD17B10 (0.68) HSD17B10ALDH1A1HPGDTSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030108892-A1 Irradiation of pyrene and dimethyl aniline in water, forming labels for oligonucleotides, proteins, ceramics, transistors, semiconductors, insulators, or glass THE UNIVERSITY OF MANCHESTER (GB) 2003-06-12 US disclosed
EP-1242360-A2 EXCIPLEXES THE VICTORIA UNIVERSITY OF MANCHESTER (GB) 2002-09-25 EP disclosed
WO-2001046121-A2 EXCIPLEXES THE VICTORIA UNIVERSITY OF MANCHESTER (GB) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108892-A1 Irradiation of pyrene and dimethyl aniline in water, forming labels for oligonucleotides, proteins, ceramics, transistors, semiconductors, insulators, or glass MDM4, PHAX, DIMT1 HSD17B10 4815/4885ALDH1A1 4658/4885HPGD 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.